Insider plans 7,500-share Novanta (NASDAQ: NOVT) Rule 144 stock sale

Rhea-AI Filing Summary

Novanta, Inc. has a new Rule 144 notice covering a planned sale of 7,500 shares of its common stock. The shares are to be sold through Merrill Private Wealth Management on NASDAQ, with an aggregate market value of 1087500 and 35775123 shares outstanding.

The shares to be sold were acquired as restricted stock units from Novanta, Inc. on 02/24/2022 (1084 shares), 01/03/2023 (4679 shares), and 01/02/2025 (1737 shares), all as equity compensation. A separate table shows that Matthijs Glastra has sold 323, 6177, 7500, and 6500 common shares in the past 3 months for gross proceeds of 41990, 803010, 1050000, and 877500.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Merrill Private Wealth Management 100 Federal Street, 12th Floor Boston MA 02110	7500	1087500	35775123	02/10/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/02/2025	Restricted Stock Units	Novanta, Inc.			1737	01/02/2025	Equity Compensation
Common	02/24/2022	Restricted Stock Units	Novanta, Inc.			1084	02/24/2022	Equity Compensation
Common	01/03/2023	Restricted Stock Units	Novanta, Inc.			4679	01/03/2023	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	01/08/2026	323	41990
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	01/09/2026	6177	803010
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	01/21/2026	7500	1050000
Matthijs Glastra C/O Novanta, Inc. 125 Middlesex Turnpike Bedford MA 01730	Common	02/02/2026	6500	877500

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What stock sale does Novanta (NOVT) disclose in this Form 144?

The notice covers a planned sale of 7,500 Novanta common shares through Merrill Private Wealth Management on NASDAQ, with an aggregate market value of 1087500 and 35775123 Novanta shares outstanding at the time referenced.

How were the 7,500 Novanta (NOVT) shares in the Form 144 acquired?

The 7,500 Novanta shares come from restricted stock units granted as equity compensation on 02/24/2022 (1084 shares), 01/03/2023 (4679 shares), and 01/02/2025 (1737 shares, all issued by Novanta, Inc. as non-cash compensation awards.

What recent Novanta (NOVT) insider sales are listed in the past 3 months?

The filing lists Matthijs Glastra selling Novanta common shares on 01/08/2026 (323 shares), 01/09/2026 (6177 shares), 01/21/2026 (7500 shares), and 02/02/2026 (6500 shares), for gross proceeds of 41990, 803010, 1050000, and 877500 respectively.

On which exchange will the Novanta (NOVT) Form 144 shares be sold?

The 7,500 Novanta common shares covered by this notice are planned for sale on NASDAQ, using Merrill Private Wealth Management as broker, with an approximate sale date indicated as 02/10/2026 in the Form 144 disclosure tables.

What does the Novanta (NOVT) Form 144 say about material information?

The person for whose account the Novanta shares are to be sold represents by signing that they do not know any material adverse information about Novanta’s current or prospective operations that has not been publicly disclosed at the time of the notice.